VentriJect

Reliable estimate of cardiorespiratory fitness in less than 3 minutes

San Francisco Bay Area, Denmark · Founded 2018 · $3.7M raised

Employees
1–10
Founded
2018
Business Model
Hardware
Total Funding
$3.7M
Last Round
$1.9M Series AAug 2025
Rounds
2

About

VentriJect is a Danish medtech company that developed Seismofit, a clinically validated device for estimating cardiorespiratory fitness (VO2max) in under 3 minutes without exercise. The technology uses seismocardiography and requires no trained staff to operate. It spun out of a cardiology research center at Aalborg University in 2018.

Summary

VentriJect is a Digital Health company based in San Francisco Bay Area, Denmark, founded in 2018. It has raised $3.7M in total across 2 rounds, most recently a $1.9M Series A round in Aug 2025. Investors include Investo, Export & Investment Fund of Denmark and Vækstfonden.

Tech & App Stack

7 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AAug 2025
$1.9M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies